Neutrophil recovery with or without G-CSF in non M3 AML patient with DA 3+7 protocol

Haematology Journal of Bangladesh

View Publication Info
 
 
Field Value
 
Title Neutrophil recovery with or without G-CSF in non M3 AML patient with DA 3+7 protocol
 
Creator Islam, Gazi Yeasinul
Khan, Mohiuddin Ahmed
Akter, Mafruha
Rahman, H N Ashiqur
Ibrahim, Md.
Masud, Md. Adnan Hasan
Farhad, Md. Nurul
Rabby, A S M Tariqur
 
Subject neutrophil recovery
G-CSF
non M3 AML
DA 3 7 protocol
 
Description Background: Induction of acute myeloid leukaemia is associated with a high incidence of treatment related mortality mostly due to neutropenia related infections. This study primarily analyses the duration of neutrophil recovery with or without G-CSF during induction with DA 3+7 in non M3 AML patients. This study also evaluates role of G-CSF in duration febrile neutropenia, hospital stay, total blood products transfusion, total number of used injectable antibiotics and remission status. Methods: It was a Quasi Experimental - Non-Randomized Controlled Trail. There were two groups a) Case = Patients receiving G-CSF b) Control= Patients not receiving G-CSF. Sampling was purposive sampling. Results:  50 patients in two group, G-CSF group (n=25) and Control group (No G-CSF) (n=25) participated in this study. Among them 54% was female and 46% was male. Median age of the participants was 28 years. Neutrophil recovery duration in G-CSF group Vs Control group showed 22.64 Vs 24.64 days (p value 0.003). Duration of febrile neutropenia in G-CSF group Vs Control group showed 11.24 Vs 13.56 days (p value 0.038). Duration of hospital stay in G-CSF group Vs Control group showed 23.64 Vs 25.76 days (p value 0.002). Total number of blood and blood product transfusion in G-CSF group Vs Control group showed 3.80 Vs 3.88 (p value 0.597). Total number of injectable antibiotics in G-CSF group Vs Control group showed 2.72 Vs 3.12 days (p value 0.169). In G-CSF group 22 (88%) and in Control group 23 (92%) were in complete remission (p value 0.637). Conclusions: G-CSF significantly reduces the duration of neutropenia (p value 0.003), febrile neutropenia (p value 0.038) and hospital stay (p value 0.002) after induction with DA 3+7. This may cause reduction in treatment cost and sepsis related mortality. G-CSF can’t significantly reduce use of blood products (p value 0.597) and injectable antibiotics (p value 0.169) after induction with DA 3+7. G-CSF does not affect morphological remission status (p value 0.637) after induction with DA 3+7.
 
Publisher Haematology Society of Bangladesh
 
Date 2021-05-06
 
Type info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
Peer-Reviewed Article
 
Format text/html
application/pdf
 
Identifier https://journal.hematologybd.org/index.php/haematoljbd/article/view/62
10.37545/haematoljbd202062
 
Source Haematology Journal of Bangladesh; Vol. 5 No. 01 (2021); 15-19
2707-1405
2523-1219
 
Language eng
 
Relation https://journal.hematologybd.org/index.php/haematoljbd/article/view/62/185
https://journal.hematologybd.org/index.php/haematoljbd/article/view/62/195
 
Rights Copyright (c) 2020 Gazi Yeasinul Islam, Mohiuddin Ahmed Khan, Mafruha Akter, H N Ashiqur Rahman, Md. Ibrahim, Md. Adnan Hasan Masud, Md. Nurul Farhad, A S M Tariqur Rabby
https://creativecommons.org/licenses/by-nc/4.0
 

Contact Us

The PKP Index is an initiative of the Public Knowledge Project.

For PKP Publishing Services please use the PKP|PS contact form.

For support with PKP software we encourage users to consult our wiki for documentation and search our support forums.

For any other correspondence feel free to contact us using the PKP contact form.

Find Us

Twitter

Copyright © 2015-2018 Simon Fraser University Library